Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001610717-26-000107
Filing Date
2026-03-18
Accepted
2026-03-18 18:02:48
Documents
2
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 9787
2 poa.txt EX-24 4000
  Complete submission text file 0001610717-26-000107.txt   15289
Mailing Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301
Business Address
Cha Albert (Reporting) CIK: 0001397906 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36815 | Film No.: 26770995

Mailing Address TUBORG BOULEVARD 12 HELLERUP Denmark
Business Address TUBORG BOULEVARD 12 HELLERUP Denmark 45 70 22 22 44
Ascendis Pharma A/S (Issuer) CIK: 0001612042 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)